nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis
|
Guzman-Prado, Yuli |
|
|
70 |
1 |
p. 89-100 |
artikel |
2 |
CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer
|
Horzum, Utku |
|
|
70 |
1 |
p. 75-87 |
artikel |
3 |
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors
|
Ichihara, Eiki |
|
|
70 |
1 |
p. 101-106 |
artikel |
4 |
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status
|
Lee, Ji Ae |
|
|
70 |
1 |
p. 47-59 |
artikel |
5 |
Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer
|
Failing, Jarrett J. |
|
|
70 |
1 |
p. 215-219 |
artikel |
6 |
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides
|
Fujiki, Fumihiro |
|
|
70 |
1 |
p. 253-263 |
artikel |
7 |
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model
|
Nicoud, Melisa B. |
|
|
70 |
1 |
p. 233-244 |
artikel |
8 |
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC
|
Bao, Xuanwen |
|
|
70 |
1 |
p. 189-202 |
artikel |
9 |
Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment
|
Kinoshita, Fumihiko |
|
|
70 |
1 |
p. 123-135 |
artikel |
10 |
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
|
Arai, Jun |
|
|
70 |
1 |
p. 203-213 |
artikel |
11 |
Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation
|
Kamakura, Daisuke |
|
|
70 |
1 |
p. 177-188 |
artikel |
12 |
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas
|
Rutland, John W. |
|
|
70 |
1 |
p. 169-176 |
artikel |
13 |
Patterns of progression in patients treated for immuno-oncology antibodies combination
|
Bernard-Tessier, Alice |
|
|
70 |
1 |
p. 221-232 |
artikel |
14 |
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma
|
Chu, Tan-Huy |
|
|
70 |
1 |
p. 31-45 |
artikel |
15 |
Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report
|
Temiz, Mustafa Zafer |
|
|
70 |
1 |
p. 245-252 |
artikel |
16 |
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
|
Shi, Yehui |
|
|
70 |
1 |
p. 61-73 |
artikel |
17 |
Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses
|
Remke, Niklas |
|
|
70 |
1 |
p. 107-121 |
artikel |
18 |
Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC)
|
Gudbrandsdottir, Gigja |
|
|
70 |
1 |
p. 19-30 |
artikel |
19 |
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma
|
Premkumar, Kavitha |
|
|
70 |
1 |
p. 153-168 |
artikel |
20 |
Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)
|
Cao, Rui |
|
|
70 |
1 |
p. 1-18 |
artikel |
21 |
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer
|
Zhang, Jiexia |
|
|
70 |
1 |
p. 137-151 |
artikel |